Literature DB >> 24812288

Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.

Nezam Altorok1, Pei-Suen Tsou2, Patrick Coit3, Dinesh Khanna2, Amr H Sawalha4.   

Abstract

BACKGROUND: The aetiology of systemic sclerosis (SSc) is not clear, but there is an emerging evidence of gene-specific epigenetic dysregulation in the pathogenesis of SSc.
METHODS: We performed a genome-wide DNA methylation study in dermal fibroblasts in six diffuse cutaneous SSc (dSSc) patients, six limited cutaneous SSc (lSSc) patients compared with 12 age-matched, sex-matched and ethnicity-matched healthy controls. Cytosine methylation was quantified in more than 485 000 methylation sites across the genome. Differentially methylated CpG sites between patients and controls with a fold difference ≥1.2 were identified. Quantitative real-time RT-PCR was performed to assess correlation between DNA methylation changes and gene expression levels.
RESULTS: We identified 2710 and 1021 differentially methylated CpG sites in dSSc and lSSc, respectively. Of the differentially methylated sites, 61% in dSSc and 90% in lSSc were hypomethylated. There were only 203 CpG sites differentially methylated in both dSSc and lSSc, representing 118 hypomethylated and 6 hypermethylated genes. Common hypomethylated genes include ITGA9, encoding an α integrin. Other relevant genes such as ADAM12, COL23A1, COL4A2 and MYO1E, and transcription factors genes RUNX1, RUNX2 and RUNX3 were also hypomethylated in both dSSc and lSSc. Pathway analysis of differentially methylated genes in both dSSc and lSSc revealed enrichment of genes involved in extracellular matrix-receptor interaction and focal adhesion. We demonstrate significant correlation between DNA methylation status and gene expression in the majority of genes evaluated.
CONCLUSIONS: Our data highlight common and subset-specific aberrancies in dSSc and lSSc fibroblasts at the epigenomic levels and identify novel candidate genes in SSc. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Autoimmunity; Fibroblasts; Systemic Sclerosis

Mesh:

Year:  2014        PMID: 24812288      PMCID: PMC4224992          DOI: 10.1136/annrheumdis-2014-205303

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  53 in total

1.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

Review 2.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

4.  Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Yoshihiro Mimura; Kunihiko Tamaki
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation.

Authors:  Sergio Carracedo; Ning Lu; Svetlana N Popova; Roland Jonsson; Beate Eckes; Donald Gullberg
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

6.  Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury.

Authors:  Sophie Dulauroy; Selene E Di Carlo; Francina Langa; Gérard Eberl; Lucie Peduto
Journal:  Nat Med       Date:  2012-07-29       Impact factor: 53.440

7.  Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus.

Authors:  Matlock A Jeffries; Mikhail Dozmorov; Yuhong Tang; Joan T Merrill; Jonathan D Wren; Amr H Sawalha
Journal:  Epigenetics       Date:  2011-05-01       Impact factor: 4.528

8.  Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.

Authors:  David Egging; Ivonne van Vlijmen-Willems; Tomas van Tongeren; Joost Schalkwijk; Anita Peeters
Journal:  Connect Tissue Res       Date:  2007       Impact factor: 3.417

9.  Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression.

Authors:  Lorenzo de la Rica; José M Urquiza; David Gómez-Cabrero; Abul B M M K Islam; Nuria López-Bigas; Jesper Tegnér; René E M Toes; Esteban Ballestar
Journal:  J Autoimmun       Date:  2013-01-08       Impact factor: 7.094

10.  Fibrosis in systemic sclerosis: common and unique pathobiology.

Authors:  Swati Bhattacharyya; Jun Wei; Warren G Tourtellotte; Monique Hinchcliff; Cara G Gottardi; John Varga
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06
View more
  55 in total

Review 1.  The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?

Authors:  Masaru Kato; Shinsuke Yasuda; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2018-04-05       Impact factor: 2.631

2.  Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells.

Authors:  Patrick Coit; Paul Renauer; Matlock A Jeffries; Joan T Merrill; W Joseph McCune; Kathleen Maksimowicz-McKinnon; Amr H Sawalha
Journal:  J Autoimmun       Date:  2015-05-23       Impact factor: 7.094

Review 3.  Epigenetics and systemic sclerosis.

Authors:  Nezam Altorok; Bashar Kahaleh
Journal:  Semin Immunopathol       Date:  2015-07-11       Impact factor: 9.623

4.  Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils.

Authors:  Patrick Coit; Srilakshmi Yalavarthi; Mikhail Ognenovski; Wenpu Zhao; Sarfaraz Hasni; Jonathan D Wren; Mariana J Kaplan; Amr H Sawalha
Journal:  J Autoimmun       Date:  2015-01-28       Impact factor: 7.094

Review 5.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

Review 6.  Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  FASEB J       Date:  2020-05-23       Impact factor: 5.191

Review 7.  New insights into the epigenetics of inflammatory rheumatic diseases.

Authors:  Esteban Ballestar; Tianlu Li
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 8.  Clinical value of DNA methylation markers in autoimmune rheumatic diseases.

Authors:  Esteban Ballestar; Amr H Sawalha; Qianjin Lu
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

Review 9.  Emerging role of epigenetics in systemic sclerosis pathogenesis.

Authors:  M Ciechomska; J M van Laar; S O'Reilly
Journal:  Genes Immun       Date:  2014-07-17       Impact factor: 2.676

10.  Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.

Authors:  Ye He; Pei-Suen Tsou; Dinesh Khanna; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2018-05-14       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.